Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine (Q56773016)
Jump to navigation
Jump to search
scientific article published on 15 July 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine |
scientific article published on 15 July 2011 |
Statements
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine (English)
A Piciocchi
C Matteucci
L Brandimarte
C Finelli
E Pogliani
G Fioritoni
M Greco
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference